Non-Oncogene Addiction to BRD in CLL: from JQ1 Response to Resistence
Despite significant advances in the molecular characterization of Chronic Lymphocytic Leukemia (CLL), CLL remains basically incurable and patients generally relapse after an initial response to standard care treatments, principally consisting in immuno-chemotherapy regimens.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Giovanna Carr à, Sabrina Crivellaro, Cristina Panuzzo, Deborah Morena, Marcello Lingua, Giuseppe Saglio, Riccardo Taulli, Alessandro Morotti Source Type: research
More News: Addiction | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Lymphoma | Myeloma